Abstract Previous research has suggested autoimmune diseases are risk factors for developing venous thromboembolism (VTE). We assessed whether having diagnoses of selected autoimmune diseases associated with antiphospholipid antibodies-autoimmune hemolytic anemia (AIHA), immune thrombocytopenic purpura (ITP), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE)-were associated with having a VTE diagnosis among US adult hospitalizations. A cross-sectional study was conducted using the 2010 Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality. VTE and autoimmune diseases were identified using International Classification of Diseases, Ninth Revision, Clinical Modification coded diagnoses information. The percentages of hospitalizations with a VTE diagnosis among all non-maternal adult hospitalizations without any of the four autoimmune diseases of interest and among those with AIHA, ITP, RA, and SLE diagnoses were 2.28, 4.46, 3.35, 2.65 and 2.77 %, respectively. The adjusted odds ratios (OR) for having a diagnosis of VTE among non-maternal adult hospitalizations with diagnoses of AIHA, ITP, RA, and SLE were 1.25 [95 % confidence interval (CI) 1.05-1.49], 1.20 (95 % CI 1.07-1.34), 1.17 (95 % CI 1.13-1.21), and 1.23 (95 % CI 1.15-1.32), respectively, when compared to those without the corresponding conditions. The adjusted OR for a diagnosis of VTE associated with a diagnosis of any of the four autoimmune diseases was 1.20 (95 % CI 1.16-1.24). The presence of a diagnosis of AIHA, ITP, RA, and SLE was associated with an increased likelihood of having a VTE diagnosis among the group of all nonmaternal adult hospitalizations.
Introduction
Venous thromboembolism (VTE), which consists of deep vein thrombosis (DVT) and pulmonary embolism (PE), is an important health concern [1] [2] [3] . Research in the past several years has increasingly suggested that autoimmune diseases may be risk factors for VTE occurrence [4] . These have included studies that have reported a higher risk of VTE associated with autoimmune hemolytic anemia (AIHA), immune thrombocytopenic purpura (ITP), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE), as well as several other autoimmune diseases [5] [6] [7] [8] [9] [10] [11] . For example, investigators in a case-control study among outpatients in a hospital in Italy found that SLE was one of the factors significantly associated with idiopathic DVT (OR 4.31, 95 % CI 3.14-5.48) [12] . A study among 30 patients with AIHA in the US found that 8 (27 %) of
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Hospitalized patients with autoimmune disorders may particularly be at risk of VTE. Hospitalization itself is a strong risk factor for VTE [13, 14] ; reasons for this likely include the VTE risks associated with immobility, surgery, and co-morbid conditions. Hospitalized patients with autoimmune diseases therefore may be at risk of hospital associated VTE because of the effects of both factors. Increased epidemiologic understanding of the association between autoimmune diseases and VTE can help to better assess the risk for VTE among hospitalized patients and develop and implement appropriate prevention strategies. This study assesses the association between VTE, whether occurring during or before hospitalization, and selected autoimmune diseases in a large sample of hospitalizations in the US; we focus on the autoimmune diseases, SLE, RA, ITP, and AIHA. Our objectives were to estimate the percent of hospitalizations with recorded diagnoses of AIHA, ITP, RA, SLE, or any combination of these diseases that also had recorded diagnoses of VTE and to assess if those with these autoimmune diseases had an increased likelihood of having a VTE diagnosis compared to hospitalizations without these diagnoses.
Methods
This study used data from the National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. In 2010, the Nationwide Inpatient Sample database included information on inpatient stays from approximately 1,000 hospitals (*20 % of community hospitals in the US) in 45 states (comprising 96 % of the US population). Information collected on each discharge included dates of hospitalization, patient's sex, age, and race/ethnicity as well as International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) coded information on diagnoses and performed procedures. The dataset also includes information on whether the patient underwent major surgery during the hospitalization (derived from ICD-9-CM coded information available for the hospitalization). More detailed information about the Nationwide Inpatient Sample data is available at the following website: http://www.hcup-us.ahrq.gov/nisoverview.jsp.
A cross-sectional approach was used with hospitalization as the unit of analysis. All hospitalizations for nonmaternal causes (did not have a maternal diagnosis or procedure) where the patient's age was C19 years were included in this study. Hospitalizations with recorded diagnoses of VTE were defined as those with ICD-9-CM codes indicating diagnoses of DVT, PE, or both, as any of the up to 25 listed diagnoses. The diagnosis of the four selected autoimmune diseases and the presence of selected medical conditions (cancer, congestive heart failure, stroke, long bone fracture, infection) that have been reported to be risk factors [3, 15] for VTE as well as venous catheterization [3] (also a reported risk factor for VTE) during hospitalization were also identified using ICD-9-CM coded diagnoses and procedure information. The ICD-9-CM codes used in this study to identify various diagnoses and venous catheterization are presented in Appendix.
Analysis
The association of a diagnosis of VTE with the recorded diagnosis of each or any of the 4 selected autoimmune diseases was assessed using logistic regression analysis. Unadjusted odds ratios (OR) for recorded diagnoses of VTE associated with hospitalizations with recorded diagnoses of AIHA, ITP, RA, or SLE (when compared to hospitalizations without a diagnosis of the respective autoimmune disease) were derived using a separate model for each disease where only the disease was included as the explanatory variable; adjusted OR were derived using a model where the explanatory variables were all four autoimmune diseases of interest, patient sex, age, race/ ethnicity, length of hospital stay, selected medical conditions, venous catheterization, and major surgery. Similarly, in separate models, unadjusted and adjusted OR were also derived for hospitalizations with a recorded diagnosis of any (i.e. one or more) of the four autoimmune diseases (a composite variable). To assess if there were effect modifications by sex and age-group, we conducted logistic regression analysis where we included in the model twoway interaction terms between each of the autoimmune diseases and sex and between each of the autoimmune diseases and age-group, and three-way interaction terms between each of the autoimmune diseases, sex and agegroup, as well as the main effects variables for these factors and the other adjustment variables. SAS version 9.3 (SAS Institute, Inc.) was used to conduct the analysis. Complex survey data analysis procedures (proc surveyfreq and proc surveylogistic) were used to adjust for the Nationwide Inpatient Sample sampling design, accounting for weights, strata, and clusters. The analysis was weighted to represent all non-maternal hospitalizations in the US among adults C19 years of age occurring in the types of hospitals included in the Healthcare Cost and Utilization Project, Nationwide Inpatient Sample data base. Observations with missing information on the patient's sex (0.1 %) and length of hospital stay (0.01 %) were excluded from regression analyses.
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Observations with missing race/ethnicity information (11 %) were classified into a 'missing information' response category for the race/ethnicity variable.
Results
In the study sample, there were 5,675,929 observations of hospitalizations among adults C19 years of age that were not because of maternal causes (hereafter referred to simply as hospitalizations of both women and men) and of these, 136,120 hospitalizations had recorded diagnoses of one or more of the four autoimmune diseases of interest; 103,653 of these were among non-maternal hospitalizations of adult women (hereafter referred to simply as hospitalizations of women) and 32,445 were among hospitalizations of adult men (hereafter referred to simply as hospitalizations of men). Table 1 . The adjusted OR for recorded diagnoses of VTE was highest among hospitalizations of both women and men with recorded diagnoses of AIHA, followed by SLE, ITP, and RA (when compared to hospitalization of men and women without the respective autoimmune disease in each case). The adjusted OR for a diagnosis of VTE among hospitalizations of both women and men with any of the four autoimmune disorders was 1.20 (95 % CI 1.16-1.24) compared to hospitalizations of both women and men without the four autoimmune diseases. Of the two-way interactions with sex, only those between sex and SLE and sex and ITP were statistically significant (p \ 0.05); with regard to age-group, a two-way interaction was statistically significant (p \ 0.05) only for SLE. A three-way interaction was statistically significant (p \ 0.05) only for ITP. Table 4 . The highest OR for VTE associated with a diagnosis of ITP (when compared to not having a diagnosis of ITP) was among hospitalizations of women 19-40 years of age (OR 1.66, 95 % CI 1.12-2.45). Though the three-way interaction was not statistically significant for SLE, the highest OR for VTE associated with a diagnosis of SLE (compared to not having a diagnosis of SLE) was among hospitalizations of men 19-40 years of age (OR 2.79, 95 % CI 2.16-3.61).
Discussion
Our findings indicate that among non-maternal hospitalizations of adult patients in the United States, a recorded diagnosis of AIHA, ITP, RA, and SLE was significantly associated with an increased likelihood of having a recorded diagnosis of VTE. The percent of hospitalizations with a VTE diagnosis among those with a diagnosis of SLE was somewhat higher among hospitalizations of men compared to hospitalizations of women; the odds ratio for VTE diagnosis associated with an SLE diagnosis (compared to not having an SLE diagnosis) was also somewhat higher among hospitalizations of men than among hospitalizations of women. Age also appeared to be a significant effect modifier for the association with SLE where the OR for a VTE diagnosis associated with an SLE diagnosis (compared to not having an SLE diagnosis) was higher among hospitalizations of both women and men 19-40 years of age compared to hospitalizations of older women and men, with the OR being less than one and not statistically significant for hospitalizations of those C61 years of age. When stratified by both sex and age-group, the highest odds ratio for a VTE diagnosis associated with an ITP diagnosis (compared to not having an ITP diagnosis) was among hospitalizations of women 19-40 years of age. The findings of the current study add to the evidence suggesting that selected autoimmune diseases are associated with VTE occurrence.
There are several reasons why autoimmune disease may increase the risk of VTE. These reasons include that autoimmune diseases are commonly marked by inflammation, which increases the likelihood of thrombosis through several mechanisms including dysfunction of endothelium, increased tissue factor expression, increased levels of plasminogen activator inhibitor 1, and impairment of the protein C anticoagulant system [11, 16] . Also, higher levels of antiphospholipid antibodies (aPL) have been reported for SLE, RA, thyroid disease, and ITP, and other autoimmune diseases [11, 17] . Antiphospholipid antibodies may result in hypercoagulability and thrombosis by affecting the interaction between cell surface phospholipids and coagulation related proteins and possibly through other mechanisms as well [5, 11, 18, 19] . It is important to note there may be a higher risk of VTE regardless of the aPL status as other factors may influence thrombosis [5, 9, 11] . For example, it has been found that a substantial percent (*40 %) of SLE patients that suffer thrombosis do not The analysis was weighted to represent all non-maternal hospitalizations among adults C19 years age in non-rehabilitation community hospitals
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In adjusted analysis, the factors adjusted for are sex, race/ethnicity, age, selected medical risk factors (cancer, congestive heart failure, stroke, long bone fracture, and infection), venous catheterization, major surgery, and length of hospital stay. Since all four autoimmune diseases were included in a model, the results for each are adjusted with respect to the other three OR odds ratio, CI confidence interval, VTE venous thromboembolism Risk of VTE among hospitalizations 309 have aPL [5] . It is also possible that an increased risk of VTE results, at least partially, from glucocorticoid therapy that may be associated with autoimmune diseases. A number of studies have indicated that glucocorticoids may increase the risk of VTE [20] [21] [22] [23] [24] . However, a review study reported that research findings showed that glucocorticoids had differential effects depending on the situation assessed [21] . Possible mechanisms of how glucocorticoids may increase VTE risk may include increased clotting factor and fibrinogen levels resulting from glucocorticoids [20, 21] . Another possible reason for the increased risk of VTE is that it is, at least in part, because of the increased risk of VTE that may be associated with chemotherapy, as chemotherapeutic agents may be used in the treatment of autoimmune diseases [25, 26] . More research is needed to better understand the reasons for the possible increased risk of VTE among patients with autoimmune diseases. The increased OR for recorded diagnoses of VTE diagnosis among hospitalizations with diagnoses of the autoimmune diseases assessed in this study are consistent with a number of previous reports suggesting these disorders increase risk for developing VTE [5-10, 27, 28] . In a population-based cohort study conducted in Denmark that investigated the association between chronic ITP and VTE, it was found that the incidence risk ratio (IRR) for a primary diagnosis of VTE among patients with chronic ITP, compared to those in the reference group, was 2.65 (95 % CI 1.27-5.50); for provoked VTE (those with VTE related to cancer, fracture, trauma, surgery, or pregnancy/delivery) the IRR was 3.16 (95 % CI 1.11-8.98), and for unprovoked VTE, the IRR was 2.26 (95 % CI 0.81-6.30) [7] . Because of unavailable information, our study did not identify chronic ITP cases separately. A very serious possible complication of ITP is severe bleeding. Therefore, the possible increased risk of VTE among at least some ITP patients may cause additional difficulties in the clinical management of these patients; in addition, more investigation of this is needed.
A study using US hospital discharge data reported that among hospitalizations without joint surgery, the relative risk for VTE among hospitalizations of patients with RA, compared to those without the disorder, was 1.99 (95 % CI 1.98-2.00) [6] . In addition, in a study conducted in China, the standard incidence ratio (SIR) for VTE among SLE patients in two hospitals (as compared to the general regional population) was found to be 11.9 (95 % CI 7.3-19.6) [29] . In that study, the SIR was higher for SLE patients in younger age groups than for those in older age groups. The magnitude of the ORs associated with autoimmune diseases that have been reported by a number of other studies are substantially higher than found in our study [7, 9, 29] . Possible reasons for this may include differences in study designs and populations assessed. For instance, we used a cross-sectional approach to assess the risk of VTE diagnosis among hospitalizations with the four autoimmune diseases where the comparison group was all other nomaternal adult hospitalizations which themselves may have been at a higher risk of VTE diagnosis because hospitalized patients are more likely to have a VTE [1, 3] and because of other factors (e.g. other comorbidities that are risk factors for VTE). This could have resulted in the ORs found in our study being lower than they would have been if the comparison group was non-hospitalized persons.
Limitations of this study include that we used secondary data, and not data directly collected by the investigators through medical chart review. ICD-9-CM coded VTE diagnosis information recorded in discharge data are not always accurate. However, very good positive predictive The analysis was weighted to represent all non-maternal hospitalizations among adults C19 years age in non-rehabilitation community hospitals
The reference group for the odds ratios is all hospitalizations without the respective autoimmune disease In adjusted analysis, the factors adjusted for are race/ethnicity, age, selected medical risk factors (cancer, congestive heart failure, stroke, long bone fracture, and infection), venous catheterization, major surgery, and length of hospital stay. Since all four autoimmune diseases were included in a model, the results for each are adjusted with respect to the other three OR odds ratio, CI confidence interval, VTE venous thromboembolism values, 75-95 %, have been reported to be associated with many of the ICD-9-CM codes used to identify VTE diagnosis in this study [30] . The unit of study was the hospitalization and not the patient and it is likely some patients had more than one hospitalization in the study sample. Many of the VTE events among patients in this The analysis was weighted to represent all non-maternal hospitalizations among adults C19 years age in non-rehabilitation community hospitals
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The reference group for the odds ratios is all hospitalizations without the respective autoimmune disease In adjusted analysis, the factors adjusted for are race/ethnicity, selected medical risk factors (cancer, congestive heart failure, stroke, long bone fracture, and infection), immune thrombocytopenic purpura, rheumatoid arthritis, venous catheterization, major surgery, and length of hospital stay. Since all four autoimmune diseases were included in a model, the results for each are adjusted with respect to the other three OR odds ratio, CI confidence interval Risk of VTE among hospitalizations 311 study may have occurred prior to hospitalization; however we did not have adequate information to identify all of these separately. Similarly, we were not able to assess VTE occurring after discharge from the hospital. Also, we did not have information regarding administration of VTE prophylaxis, which may have reduced the likelihood of VTE among hospitalized patients, and thus could not account for this. Similarly, we could not account for therapy, including glucocorticoids, or other treatment received by patients for autoimmune diseases that could have affected their disease condition and thus could have affected VTE occurrence. We also could not account for the status of autoimmune disease, e.g. acute state or under control. It was also possible that other factors could have affected or modified the associations between autoimmune diseases and VTE, but assessment for such was beyond the scope of the current study. Strengths of our study include that we were able to assess the association between VTE and the four autoimmune diseases in a large sample of hospitalizations from across the US. We were also able to control for selected demographic characteristics and comorbidities during the analysis. The autoimmune diseases, AIHA, ITP, RA, and SLE may be associated with an increased risk of VTE among hospitalized patients. The risk of VTE among patients with SLE may vary by sex and by age-group. Current VTE prevention guidelines of the American College of Chest Physicians indicate antiphospholipid syndrome as a risk factor for VTE when assessing risk level among hospitalized medical patients. Such guidelines can help in clinical decision making regarding patients for consideration for VTE prophylaxis [31] . Also, additional research can help develop a more comprehensive understanding of the effect of autoimmune diseases on VTE risk among hospitalized patients.
